Search - tctmd.com

Displaying 541 - 560 of 714

Sort: Relevancy | Date

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Presenter: Dean J. Kereiakes, Ron Waksman, Davide Capodanno, Michael Haude

October 12, 2015

Presentation TCT 2015

Intravascular Imaging: IVUS, OCT, and NIRS

Presenter: John McB. Hodgson, Allen Jeremias

October 12, 2015

Presentation TCT 2015

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

FFR, CFR, and PCI

Presenter: Verghese Mathew, Arnold Seto

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

DAPT Duration After DES: Does 1 Size Fit All? Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, John A. Bittl

October 12, 2015

Presentation TCT 2015

DAPT Duration After DES: Does 1 Size Fit All?

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, John A. Bittl

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Rahul Sakhuja

October 12, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Acute Stroke Intervention From Pathophysiology to Management

Presenter: Leo Nelson Hopkins, Sahil A. Parikh, David E. Thaler

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Molly Szerlip

October 12, 2015

Presentation TCT 2015

A Tribute to Liliana Grinfeld

Presenter: Dimitrios Alexopoulos, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

Presentation TCT 2015

Future Directions: HD-IVUS, Micro-CT, Hybrid Catheters, and More

Presenter: Ziad A. Ali, Peter J. Fitzgerald, Akiko Maehara

October 11, 2015

Presentation TCT 2015

Assessment of Progression and Regression by IVUS, RF-IVUS, OCT, and NIRS: Changes of Plaque Volume vs Changes in Tissue Components and Lessons Learned

Presenter: Ziad A. Ali, Peter J. Fitzgerald, Hector M. Garcia-Garcia

October 11, 2015

Advertisement

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Intravascular Imaging: IVUS, OCT, and NIRS

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

FFR, CFR, and PCI

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies

DAPT Duration After DES: Does 1 Size Fit All? Focused Commentary

DAPT Duration After DES: Does 1 Size Fit All?

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

KEYNOTE LECTURE: Acute Stroke Intervention From Pathophysiology to Management

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

A Tribute to Liliana Grinfeld

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

Future Directions: HD-IVUS, Micro-CT, Hybrid Catheters, and More

Assessment of Progression and Regression by IVUS, RF-IVUS, OCT, and NIRS: Changes of Plaque Volume vs Changes in Tissue Components and Lessons Learned

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content